Federal Circuit

  • A Murky Ruling

    High Court's decision on obviousness leaves patent attorneys scratching their heads.

  • Court Rejects Patent as Obvious Following KSR

    The Federal Circuit's first stab at applying a recent Supreme Court patent ruling suggests that the specialized court has bowed to a command from above to more vigorously weed out bad patents granted to obvious inventions.

  • Protecting Profits

    Congress prepares to stop drug makers from offering exclusion payments to generic manufacturers.

  • Global Heartburn

    Federal Circuit makes it harder for patent owners to enforce their rights worldwide.

  • Protecting Profits

    Congress prepares to stop drug makers from offering exclusion payments to generic manufacturers.

  • Global Heartburn

    Federal Circuit makes it harder for patent owners to enforce their rights worldwide.

  • Shifting the Balance

    Companies rethink IP licensing strategies in the wake of MedImmune.

  • Shifting the Balance

    Companies rethink IP licensing strategies in the wake of MedImmune.

  • Court Restricts Rights of Patent Licensees

    When Propat International licensed a patent for e-mail authentication technology from Authentix, the company thought it was getting robust rights to use and enforce the patent. The agreement gave Propat, a Houston-based licensing company, authority to sell licenses and sue infringers, sharing the profits with Authentix. But when Propat went...

  • Eli Lilly Wins Patent Protection

    Eli Lilly faced some significant ?? 1/2 hurdles in 2006. After losing $65 million in a patent dispute against competitor Ariad Pharmaceuticals Inc., the pharmaceutical giant faced another scare over the possibility of losing its patent on its blockbuster antipsychotic drug Zyprexa. However, Lilly's luck changed Dec. 26, when the...

Advertisement. Closing in 15 seconds.